Results 1 to 10 of about 75,611 (308)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae. [PDF]

Int J Microbiol, 2023
Carbapenem is a broad-spectrum beta-lactam antibiotic considered the last choice for the treatment of antibiotic-resistant Gram-negative bacteria. Thus, the increasing rate of carbapenem resistance (CR) in Enterobacteriaceae is an urgent public health ...
Armin S, Fallah F, Karimi A, Karbasiyan F, Alebouyeh M, Rafiei Tabatabaei S, Rajabnejad M, Mansour Ghanaie R, Fahimzad SA, Abdollahi N, Khodaei H, Azimi L.   +11 more
europepmc   +5 more sources

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

New England Journal of Medicine, 2019
Plazomicin for Severe Resistant Infection This report compared plazomicin with colistin for the treatment of severe (bloodstream or pneumonia) infection with carbapenem-resistant Enterobacteriaceae...
J. McKinnell, J. Dwyer, G. Talbot, L. Connolly, I. Friedland, Alex Smith, A. Jubb, A. Serio, K. Krause, G. Daikos   +9 more
semanticscholar   +6 more sources

Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review

Infection and Drug Resistance, 2021
Mihret Tilahun, Yeshimebet kassa, Alemu Gedefie, Melaku Ashagire Department of Medical Laboratory Sciences, College of Medicine and Health Science, Wollo University, Dessie, EthiopiaCorrespondence: Mihret TilahunDepartment of Medical Laboratory Science ...
Tilahun M, kassa Y, Gedefie A, Ashagire M   +3 more
doaj   +2 more sources

Management of carbapenem-resistant Enterobacteriaceae infections. [PDF]

Clinical Microbiology and Infection, 2019
BACKGROUND Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp.,
E. Durante-Mangoni, Roberto Andini, R. Zampino   +2 more
semanticscholar   +4 more sources

Hospital-Acquired Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Observational Study. [PDF]

Microorganisms, 2023
Worldwide, hospital-acquired infections (HAIs) are continuously rising within healthcare settings, leading to high mortality and morbidity rates. Many hospitals have reported the spread of carbapenemases globally, specifically within the E.
Aldali HJ, Khan A, Alshehri AA, Aldali JA, Meo SA, Hindi A, Elsokkary EM.   +6 more
europepmc   +2 more sources

Carbapenem Resistant Enterobacteriaceae in Africa

Borneo Journal of Pharmacy, 2020
Carbapenems are regarded as unique among the β-lactam antibiotics due to their broad spectrum of activity and ability to resist β-lactamase hydrolysis.
Bashar Haruna Gulumbe, Olumide Ajibola
doaj   +3 more sources

Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae

Annals of Medicine, 2022
Introduction Occurrence of colistin-resistant Enterobacteriaceae in response to the unregulated use of this antibiotic has been documented. This study reports an investigation of colistin resistance rates among carbapenem-resistant enterobacterial ...
Hadir A. El-Mahallawy, Marwa El Swify, Asmaa Abdul Hak, Mai M. Zafer   +3 more
doaj   +2 more sources

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China [PDF]

Annals of Clinical Microbiology and Antimicrobials, 2019
Background Carbapenems are β-lactam antibiotics which are used to treat severe infections caused by multidrug resistant Enterobacteriacea. The recent emergence and rapid spread of Enterobacteriaceae resistant to carbapenems is a global concern.
Yijun Ding, Yajuan Wang, Yingfen Hsia, Mike Sharland, Paul T. Heath   +4 more
doaj   +3 more sources

Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare–associated Infections Surveillance Data, 2011–2017

Antimicrobial Resistance and Infection Control, 2020
Objective To describe the epidemiology of carbapenem-resistant Enterobacteriaceae (CRE) healthcare-associated infections (HAI) in Egyptian hospitals reporting to the national HAI surveillance system.
Sara Kotb, Meghan Lyman, Ghada Ismail, Mohammad Abd El Fattah, Samia A. Girgis, Ahmed Etman, Soad Hafez, Jehan El-Kholy, Maysaa El Sayed Zaki, Hebat-allah G. Rashed, Ghada M. Khalil, Omar Sayyouh, Maha Talaat   +12 more
doaj   +2 more sources

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections

Antibiotics, 2019
Carbapenem-resistant Enterobacteriaceae (CRE) have become a public health threat worldwide. There are three major mechanisms by which Enterobacteriaceae become resistant to carbapenems: enzyme production, efflux pumps and porin mutations.
Beatriz Suay-García, María Teresa Pérez-Gracia   +1 more
doaj   +2 more sources